Diagnostics & Tools July 2021

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• PerkinElmer has agreed to acquire BioLegend $5.25bb
• Pacific Biosciences of California has agreed to acquire Omniome for approximately $760mm
• Vitrolife has agreed to acquire Igenomix for $1.48bb